Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-029459
Filing Date
2025-12-29
Accepted
2025-12-29 19:19:12
Documents
1
Period of Report
2025-12-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4216
  Complete submission text file 0001493152-25-029459.txt   5740
Mailing Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432
Business Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Issuer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2390 EAST ORANGEWOOD SUITE 570 ANAHEIM CA 92806
Business Address
Felix Lourdes (Reporting) CIK: 0001569735 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39717 | Film No.: 251610782